Top 20 Oxyrane UK investors
The most complete profiles first. Showing 20 of 20.
Antoine BoulangerVerified
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Anastasia KarpovaVerified
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Andrew AbramsVerified
Venture Capital, Private Equity Firm, Micro VC · United Kingdom
Health CareTelecommunicationsGeneticsCybersecurityPortfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more
Verified email available
JeanVerified
Micro VC · United States
Health CareTelecommunicationsGeneticsCybersecurityPortfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more
Verified email available
John MontanaVerified
Venture Capital, Private Equity Firm, Investment Partner · United Kingdom
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Raju MohanVerified
Micro VC · United States
Health CareTelecommunicationsGeneticsCybersecurityPortfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more
Verified email available
Somu SubramaniamVerified
Micro VC · United States
Health CareTelecommunicationsGeneticsCybersecurityPortfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more
Verified email available
Thomas LavinVerified
Venture Capital, Private Equity Firm, Micro VC · United States
Health CareTelecommunicationsGeneticsCybersecurityPortfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more
Verified email available
Geert
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Holger Reithinger
Venture Capital, Investor · Germany
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Juliette Audet
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Martien van Osch
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Rogier Rooswinkel
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Wouter Joustra
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Asiya Giniatullina
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Bonnie van Wilgenburg
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Carlo Incerti
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Sander van Deventer
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Vincent van Houten
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Vivek Mohindra
Micro VC · United States
Health CareTelecommunicationsGeneticsCybersecurityPortfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more
Contact details available
Frequently asked questions
How many Oxyrane UK investors are on Angel Roster?
Angel Roster lists 20 Oxyrane UK investors. 8 of them (40%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (16), Private Equity Firms (8) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Oxyrane UK investors invest in?
Among those that list a stage, the most common are Seed (7).
Where are Oxyrane UK investors based?
Most are based in the Netherlands (12), the United States (5) and the United Kingdom (2).
Which companies have Oxyrane UK investors backed?
The most-backed portfolio companies among them are NorthSea Therapeutics (20), Ario Pharma (20), Akarna Therapeutics (20), Escalier Biosciences (20) and Dezima Pharma (20).
How do I contact Oxyrane UK investors?
Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.